Document Detail


Staining of MUC1 in ovarian cancer tissues with PankoMab-GEX™ detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8.
MedLine Citation:
PMID:  23275306     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
PankoMab-GEX™ is a novel humanized and glycooptimized antibody, which recognizes a novel specific tumour epitope of MUC1 (TA-MUC1). The aim of this study was to evaluate PankoMab-GEX™ binding to a variety of ovarian cancer specimens (n=156) and to normal ovarian tissue. In addition, PankoMab-GEX™ staining was compared to that of the well-known anti-MUC1 antibodies HMFG-1 and 115D8. PankoMab-GEX™ showed positive reactivity in serous (100% of cases, mean IRS 8.23), endometrioid (95% of cases, mean IRS 6.40), mucinous (58% of cases, mean IRS 4.17), and clear cell (92% of cases, mean IRS 7.58) carcinomas. In contrast to HMFG-1, healthy ovarian tissue was not recognized by PankoMab-GEX™. Staining with antibody 115D8 was increased with staging. Cytoplasmic PankoMab-GEX™ staining increased with tumour grade, but no correlation was found with staging. Univariate Kaplan-Meier analysis revealed a tendency of reduced survival of patients with high expression of TA-MUC1. The findings are encouraging with respect to a potential use of PankoMab-GEX™ as a new therapeutic antibody for the treatment of ovarian cancer patients.
Authors:
D Dian; M Lenhard; D Mayr; S Heublein; U Karsten; S Goletz; C Kuhn; I Wiest; K Friese; T Weissenbacher; U Jeschke
Related Documents :
20377426 - Igg subclass profiles in infected hiv type 1 controllers and chronic progressors and in...
8812676 - Immunonegative staining: epitope localization on macromolecules
6394336 - Intravenous administration of human igg to newborn infants: changes in serum antibody l...
10405926 - Igg 1 subclass specificity for igg rheumatoid factors in patients with rheumatoid arthr...
71736 - Key antigenic determinants in regulation of the immune response.
24671426 - Mage-a3 with cell-penetrating domain as an efficient therapeutic cancer vaccine.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Histology and histopathology     Volume:  28     ISSN:  1699-5848     ISO Abbreviation:  Histol. Histopathol.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2012-12-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8609357     Medline TA:  Histol Histopathol     Country:  Spain    
Other Details:
Languages:  eng     Pagination:  239-44     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Ludwig-Maximilians-University Munich, Munich, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thyroid hormone receptor (TR)alpha and TRbeta expression in breast cancer.
Next Document:  The effect of glucagon and cyclic adenosine monophosphate on acute liver damage induced by acetamino...